Mawson Infrastructure Group Removes CEO Rahul Mewawalla and Files Lawsuit
Mawson Infrastructure Group removes CEO Rahul Mewawalla amid legal dispute, filing lawsuit to address governance issues. #MawsonInfrastructure #CorporateGovernance
Topic
Finance
Finance news
Plum Acquisition Corp. IV Issues $1.5 Million Unsecured Note to Sponsor
Plum Acquisition Corp. IV issues $1.5M unsecured note to sponsor, supporting operational and transaction activities. #PlumAcquisition #SPACFinance
Greenwave Technology Solutions Sets Date for 2025 Annual Shareholder Meeting
Greenwave Technology Solutions announces its 2025 annual shareholder meeting date, focusing on governance and strategic updates. #GreenwaveTech #ShareholderMeeting
Skillz Appoints Todd A. Valli as Chief Accounting Officer Effective Monday
Skillz names Todd A. Valli as Chief Accounting Officer, strengthening financial leadership. #Skillz #LeadershipUpdate
Lavoro Receives Nasdaq Non-Compliance Notice for Delayed Financial Filing
Lavoro faces Nasdaq non-compliance notice due to delayed financial filings, raising regulatory and investor concerns. #Lavoro #NasdaqCompliance
Vesta Renews Market Maker Services Agreement with BTG Pactual in Mexico
Vesta extends market maker agreement with BTG Pactual, enhancing liquidity and trading efficiency in Mexico. #Vesta #BTGPactual
Safe & Green Holdings Receives Conditional Approval to Maintain Nasdaq Listing
Safe & Green Holdings obtains conditional Nasdaq approval, ensuring continued listing while addressing compliance requirements. #SafeAndGreen #NasdaqListing
Agencia Comercial Spirits Targets IPO Amid Concerns Over Excessive Valuation
Agencia Comercial Spirits plans IPO despite market concerns about high valuation. #AgenciaComercial #IPO
Piermont Valley Acquisition Corp Announces Leadership Changes and Share Transfer
Piermont Valley Acquisition Corp announces key leadership changes and share transfer, signaling strategic shifts. #PiermontValley #LeadershipUpdate
FDA Accepts Review of GSK Application to Expand Arexvy RSV Vaccine Use
FDA begins review of GSK's application to broaden Arexvy RSV vaccine use, signaling potential market expansion. #GSK #Arexvy #RSVVaccine